Top Organoids Start-ups

Top ranked companies founded since 2021 for keyword search: Organoids

Atmos Space Cargo

Company iconPrivately Held

Company founded iconFounded 2021

Company location iconGermany

ATMOS Space Cargo develops advanced space logistics technology, enabling the return of cargo from space and supporting microgravity research, commercial payloads, and spacecraft reusability. Their PHOENIX capsule serves as a versatile platform for...

Company website iconhttps://atmos-space-cargo.com

FibroBiologics, LLC

Company iconPublicly Traded

Company founded iconFounded 2021

Company location iconUSA

FibroBiologics is a Houston-based cell therapy and regenerative medicine company developing a pipeline of treatments for chronic diseases using fibroblast cells. The company’s technology is focused on fibroblast-based cell therapies intended to...

Company website iconhttp://www.fibrobiologics.com

Parallel Bio

Company iconPrivately Held

Company founded iconFounded 2021

Company location iconUSA

Parallel Bio is a biotechnology company that focuses on the development of immunotherapies. They utilize organoids, small 3D models of human organs, and advanced bioengineering and machine learning techniques for drug discovery. Their platform...

Company website iconhttps://www.parallel.bio/

MINUTIA, INC.

Company iconPrivately Held

Company founded iconFounded 2021

Company location iconUSA

Minutia Inc specializes in developing innovative solutions for type 1 diabetes treatment through stem cell-derived pancreatic islet cell therapies. The company focuses on enhancing graft resilience by utilizing genetic modifications to improve...

Company website iconhttps://www.minutia.co/

Tolerance Bio

Company iconPrivately Held

Company founded iconFounded 2023

Company location iconUSA

Tolerance Bio develops therapies that target the thymus to preserve, restore and manipulate immune tolerance. The company focuses on interventions aimed at maintaining or reprogramming thymic function-the organ that governs T-cell development and...

Company website iconhttps://www.tolerancebio.com/

mo:re

Company iconPrivately Held

Company founded iconFounded 2023

Company location iconGermany

mo:re GmbH develops automated systems for 3D cell culture and associated assays. The company's MO:BOT is an integrated laboratory platform that automates 3D cell culture workflows and downstream assays (NAMs) using validated protocols. The platform...

Company website iconhttps://more.science

Pandorum Technologies Pvt. Ltd.

Company iconPrivately Held

Company founded iconFounded 2023

Company location iconIndia

Pandorum Technologies develops programmable, tunable exosome-based regenerative therapies and tissue-engineering platforms. Its proprietary platform integrates biology, engineering, and computation to reprogram pathological tissue states like...

Company website iconhttps://pandorum.com/

ALP AI

Company iconPrivately Held

Company founded iconFounded 2025

Company location iconUSA

ALP AI applies artificial intelligence and organoid-trained immunology to redesign antibodies and reduce immunogenicity. Its tonsil organoid-trained platform predicts and mitigates anti-drug antibody (ADA) risk early in hit generation, while a...

Company website iconhttps://alpbio.ai

Prometheus Life Technologies

Company iconPrivately Held

Company founded iconFounded 2022

Company location iconSwitzerland

We developed a disruptive space proven technology to produce high quality human tissue organoids in Low Earth Orbit with the vision of improving and saving lives. Organoids are 3D in vitro culture systems derived from self-organizing stem cells,...

Company website iconhttps://plt.bio/

HeartBeat.bio

Company iconPrivately Held

Company founded iconFounded 2021

Company location iconAustria

HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies. We employ the world-wide first, self-organizing cardiac organoids (Cardioids)...

Company website iconhttp://www.heartbeat.bio/

Celloid

Company iconPrivately Held

Company founded iconFounded 2021

Company location iconSouth Korea

Celloid is a biotechnology company specializing in 3D cell culture solutions. Their innovative technology enables quality controlled, long-term culture of organoids with high homogeneity and reproducibility. Celloid's research and development...

Company website iconhttps://celloid.co.kr/

Orbits Oncology

Company iconPrivately Held

Company founded iconFounded 2023

Company location iconUSA

Orbits Oncology provides an AI software platform that transforms patient tumor data into digital patient surrogates to assist cancer researchers in making better decisions in drug development and clinical settings.

Company website iconhttps://www.orbits-oncology.com/

Vital3D Technologies

Company iconPrivately Held

Company founded iconFounded 2021

Company location iconLithuania

Vital3D Technologies is a biotechnology company specializing in advanced 3D bioprinting solutions for medical research, drug discovery, and regenerative medicine. The company's innovative technologies enable high-speed, high-precision printing of...

Company website iconhttp://www.vital3d.eu

Epiloid Biotechnology

Company iconPrivately Held

Company founded iconFounded 2022

Company location iconCanada

Epiloid Biotechnology specializes in preclinical 3D human cerebral organoid assays for novel neurological pharmaceuticals. Our analysis platform focuses on predicting preclinical human drug efficacy through machine learning analysis of biochemical...

Company website iconhttps://epiloid.framer.website/

PATH Biotech

Company iconPrivately Held

Company founded iconFounded 2021

Company location iconUSA

PATH Biotech applies a proprietary AI platform (PATHTM) to integrate multi-omics, single-cell, imaging and clinical data to identify novel druggable targets and predict precision therapeutics. AI-derived hypotheses are iteratively validated using...

Company website iconhttps://pathbiotech.com/

NextVivo

Company iconPrivately Held

Company founded iconFounded 2021

Company location iconUSA

NextVivo is a biotechnology company that specializes in immune organoid technology for drug development. They aim to create safer, more effective therapies using human-derived models. Their next-generation organoids provide 3D holistic models of...

Company website iconhttps://www.nextvivo.bio/

Biolockey Healthworks Pvt Ltd

Company iconPrivately Held

Company founded iconFounded 2023

Company location iconIndia

Biolockey specializes in research and development for point-of-care diagnostics and precision therapeutics for the healthcare sector in India and worldwide. We develop innovative therapeutic and diagnostic applications using nanobodies, antibodies,...

Company website iconhttps://www.biolockey.com/

Angios

Company iconPrivately Held

Company founded iconFounded 2021

Company location iconAustria

Angios develops cell-based therapies and preclinical platforms focused on vascular disease. Using a patented iPSC-derived method to generate human blood vessels, the company produces Blood Vessel Organoids for disease modelling, an animal-free drug...

Company website iconhttps://www.angios-bio.com

VCCT Inc.

Company iconPrivately Held

Company founded iconFounded 2021

Company location iconJapan

VC Cell Therapy (VCCT) conducts research and development in the fields of ophthalmology and regenerative medicine. Established in March 2021 as a subsidiary of the company Vision Care (VC'). We are working on the early commercialization of...

Company website iconhttps://www.vcct.jp/

Lambda Biologics

Company iconPrivately Held

Company founded iconFounded 2024

Company location iconGermany

Lambda Biologics develops and delivers organoid-based in vitro platforms, assays, and technical services for human-relevant, animal-free research. Their offerings include a curated organoid biobank, custom disease- and oncology-modeling services,...

Company website iconhttps://afs.lambda-bio.com/

Jiangsu Aiweide Biotechnology Co., Ltd.

Company iconn/a

Company founded iconFounded 2021

Company location iconUnknown

It focuses on the research and development and application of human Organ chips restore the physiological system of the human body in vitro to achieve a high degree of simulation of the structure and function of human organs.Ai Weide Bio has a...

Company website iconhttps://www.avatarget.com.cn/

Doppl

Company iconPrivately Held

Company founded iconFounded 2022

Company location iconSwitzerland

Doppl is a pioneering company in the field of organoids and organs-on-a-chip research. It operates a global, crowd-sourced database of biological samples that supports critical research and drug development while ensuring citizen donors retain...

Company website iconhttps://www.doppl.ch/

Cosmica Inc.

Company iconPrivately Held

Company founded iconFounded 2022

Company location iconUSA

Cosmica utilizes unbiased multi-scale biology coupled with machine learning algorithms to develop precision-based interventions aimed at extending human lifespan on earth and reducing health risks triggered by spaceflight exposures. Our platform...

Company website iconhttps://www.cosmica.bio/

Ovelle

Company iconPrivately Held

Company founded iconFounded 2024

Company location iconUSA

Ovelle develops in vitro gametogenesis (IVG) technologies to create human eggs from somatic cells. Using computational screening, transcription-factor and RNA-binding protein manipulation, and stem-cell culture methods, they induce meiosis in human...

Company website iconhttps://ovelle.bio/

Doppelganger Biosystem GmbH

Company iconPrivately Held

Company founded iconFounded 2021

Company location iconGermany

Doppelganger Biosystem develops and provides quantitative metabolic phenotyping technologies and services. Its QSM™ platform measures metabolite turnover across 22 core metabolic pathways, enabling single-cell, organoid and tissue (including FFPE)...

Company website iconhttps://www.doppelganger-bio.com/

Free Sign-up for VentureRadar access

or






By continuing, you agree to VentureRadar's Terms of Service, Privacy Policy and Cookie Policy.

To continue, please confirm you are not a robot